371 - Adding sputum and saliva to nasopharyngeal swab samples for PCR detection of Respiratory Syncytial Virus in adults hospitalized with acute respiratory illness may double case detection

Thursday, October 20, 2022

12:15 PM – 1:30 PM US ET

Location: Hall B + C

Presenting Author(s)

Julio A. Ramirez, MD, FACP

Chief Scientific Officer
Norton Healthcare
Louisville, Kentucky, United States

RC

Ruth Carrico, PhD, FAAN

Executive Director
Norton Healthcare
Louisville, Kentucky, United States
Ashley M. Wilde, PharmD, BCIDP

Director, Infectious Diseases Clinical Program and Research
Norton Healthcare
Louisville, Kentucky, United States
AJ

Alan Junkins, PhD, D(ABMM)

Chief of Microbiology
Norton Healthcare
Louisville, Kentucky, United States
SF

Stephen Furmanek, MPH

Norton Healthcare
Louisville, Kentucky, United States
TC

Thomas R. Chandler, MPH

Biostatistician
Norton Healthcare
Louisville, Kentucky, United States
PS

Paul S. Schulz, MD

System Epidemiologist
Norton Healthcare
Louisville, Kentucky, United States
RH

Robin Hubler, MS

Pfizer
Pfizer Inc.
Collegeville, Pennsylvania, United States
Paula Peyrani, MD

Senior Director
Pfizer, Inc
Collegeville, Pennsylvania, United States
ST

Sonali Trivedi, PhD

Director Epidemiology Clinical Scientist
Pfizer
Collegeville, Pennsylvania, United States
SU

Sonal Uppal, Ph.D.

Clinical Scientist - Senior Manager
Pfizer
Champaign, Illinois, United States
QL

Qing Liu, M.S.

Pfizer Inc.
Collegeville, Pennsylvania, United States
BG

Bradford J. Gessner, M.D., M.P.H.

Vice President Global Medical Lead for Respiratory Vaccines
Pfizer Biopharma Group
Collegeville, Pennsylvania, United States
EB

Elizabeth Begier, M.D., M.P.H.

Pfizer Vaccines
Dublin, Dublin, Ireland